Fair Value Measurements And Financial Instruments (Tables)

3 Months Ended

Apr. 04, 2015

Fair Value Disclosures [Abstract]

Summary Of Components Of Available-For-Sale Securities

The following table summarizes the components of the balance of the Company’s available-for-sale securities at April 4, 2015 and January 3, 2015 (in millions):

	April 4, 2015		January 3, 2015
Adjusted cost	$	5	$	6
Gross unrealized gains	26		24
Fair value	$	31	$	30

Summary Of Financial Assets and Liabilities Measured At Fair Value On A Recurring Basis

A summary of assets and liabilities measured at fair value on a recurring basis at April 4, 2015 and January 3, 2015 is as follows (in millions):

	Balance Sheet Classification	April 4, 2015		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Money-market securities	Cash and cash equivalents	$	219	$	219	$	—	$	—
Available-for-sale    securities	Other current assets	31		31		—		—
Foreign currency forward contracts	Other current assets	28		—		28		—
Trading securities	Other assets	315		315		—		—
Foreign currency forward    contracts	Other assets	5		—		5		—
Total assets		$	598	$	565	$	33	$	—
Liabilities
Contingent consideration	Other liabilities	$	27	$	—	$	—	$	27
Total liabilities		$	27	$	—	$	—	$	27

	Balance Sheet Classification	January 3, 2015		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Money-market securities	Cash and cash equivalents	$	729	$	729	$	—	$	—
Available-for-sale securities	Other current assets	30		30		—		—
Trading securities	Other assets	301		301		—		—
Total assets		$	1,060	$	1,060	$	—	$	—
Liabilities
Contingent consideration	Other liabilities	$	50	$	—	$	—	$	50
Total liabilities		$	50	$	—	$	—	$	50

Summary of Level 3 Fair Value Measurements of Contingent Consideration Liability

The recurring Level 3 fair value measurements of the Company's contingent consideration liability include the following significant unobservable inputs (in millions):

Contingent Consideration Liability	Fair Value as of April 4, 2015		Valuation Technique	Unobservable Input	Range
Nanostim revenue-based milestone	$	27	Probability Weighted Discounted Cash Flow	Discount Rate		5.00%
				Probability of Payment		90%
				Projected Years of Three Annual Payments	2016, 2017, 2018
Total contingent consideration liability	$	27

Unobservable Input Reconciliation of Contingent Consideration Liability

Additionally, the following table provides a reconciliation of the beginning and ending balances of the Company' contingent consideration liability associated with its Nanostim acquisition since January 3, 2015 as of April 4, 2015 (in millions):

	Nanostim
Balance as of January 3, 2015	$	50
Change in fair value of contingent consideration	(23		)
Balance as of April 4, 2015	$	27